| # | Drug | Count |
|---|---|---|
| 0 | DARBEPOETIN ALFA | 324 |
| 1 | VENETOCLAX | 185 |
| 2 | CINACALCET HYDROCHLORIDE | 145 |
| 3 | TACROLIMUS | 98 |
| 4 | BORTEZOMIB | 96 |
| 5 | DEXAMETHASONE | 93 |
| 6 | DEXAMETHASONE 1.5 MG | 93 |
| 7 | LENALIDOMIDE | 81 |
| 8 | MACITENTAN | 80 |
| 9 | AMBRISENTAN | 73 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | USODIOL | 1 | 0.0833 |
| 1 | REVUMENIB | 26 | 0.0252 |
| 2 | CAROSPIR | 1 | 0.0167 |
| 3 | LUMASIRAN | 4 | 0.0104 |
| 4 | FAMOTIDINE 10MG | 1 | 0.0093 |
| 5 | PONATINIB HYDROCHLORIDE | 33 | 0.0063 |
| 6 | DARBEPOETIN ALFA | 324 | 0.0060 |
| 7 | FILGRASTIM-AAFI | 4 | 0.0060 |
| 8 | QUIZARTINIB | 3 | 0.0043 |
| 9 | PARICALCITOL | 54 | 0.0038 |
| # | Drug class | Count |
|---|---|---|
| 0 | Erythropoiesis-stimulating Agent [EPC] | 324 |
| 1 | BCL-2 Inhibitor [EPC] | 185 |
| 2 | Corticosteroid [EPC] | 166 |
| 3 | Endothelin Receptor Antagonist [EPC] | 151 |
| 4 | Proteasome Inhibitor [EPC] | 120 |
| 5 | Thalidomide Analog [EPC] | 93 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 85 |
| 7 | Kinase Inhibitor [EPC] | 84 |
| 8 | Prostacycline Vasodilator [EPC] | 80 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 76 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vitamin D2 Analog [EPC] | 54 | 0.0076 |
| 1 | Erythropoiesis-stimulating Agent [EPC] | 324 | 0.0060 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 45 | 0.0030 |
| 3 | Vitamin D Analog [EPC] | 54 | 0.0030 |
| 4 | BCL-2 Inhibitor [EPC] | 185 | 0.0029 |
| 5 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 7 | 0.0021 |
| 6 | Interferon gamma [EPC] | 3 | 0.0021 |
| 7 | Iron Chelator [EPC] | 59 | 0.0020 |
| 8 | Macrolide Antibacterial [EPC] | 2 | 0.0020 |
| 9 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 20 | 0.0012 |